Redington Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Redington Ltd is ₹ 326.75 as of 30 Oct 15:30 . The P/E Ratio of Redington Ltd changed from 9.8 on March 2021 to 10.5 on March 2026 . This represents a CAGR of 1.16% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Redington Ltd changed from ₹ 7422 crore on March 2021 to ₹ 15592 crore on March 2026 . This represents a CAGR of 13.17% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Redington Ltd for the Jun '26 is ₹ 34965 crore as compare to the Mar '26 revenue of ₹ 33268 crore. This represent the growth of 5.1% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Redington Ltd for the Jun '26 is ₹ 750.91 crore as compare to the Mar '26 ebitda of ₹ 517.62 crore. This represent the growth of 45.07% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Redington Ltd changed from ₹ 217.04 crore to ₹ 453.49 crore over 9 quarters. This represents a CAGR of 38.75% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Redington Ltd changed from 171.45 % on March 2021 to 37.71 % on March 2026 . This represents a CAGR of -22.31% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Redington Ltd

An integrated supply chain solution provider, Redington India Limited was incorporated on 2 May, 1961.
Company is engaged in distribution of Information Technology, mobility and other technology products besides supply chain solutions.
It provides logistics, supply chain management and other support services in India, Middle East, Turkey, Africa and South Asian countries. The Company commenced its operations in the year 1993 by distributing information technology products.
From then on the company has continuously expanded its operations across India covering a broad range of IT and Telecom Products.
During the year 1994, commenced service operations for IT products, distribution of Epson and Tripplite IT products, and distribution of Samsung monitors, also commenced its operations in Northern India.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Redington Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Redington Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Redington Ltd is 25,544 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Redington Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Redington Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Redington Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of November 1, 2026, the Redington Ltd stock price is INR ₹326.75. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Redington Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Redington Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.